| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J1447 |
Injection, tbo-filgrastim, 1 microgram |
14,944 |
1,547 |
$39.00M |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,720 |
1,490 |
$665K |
| J9271 |
Injection, pembrolizumab, 1 mg |
44 |
36 |
$595K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,988 |
2,811 |
$470K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,662 |
2,301 |
$463K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17,791 |
2,315 |
$389K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,495 |
2,115 |
$311K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
17,257 |
2,907 |
$264K |
| 96367 |
|
3,986 |
1,999 |
$259K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,090 |
4,773 |
$224K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,121 |
5,327 |
$169K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,762 |
1,368 |
$152K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,584 |
1,156 |
$144K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,804 |
1,674 |
$105K |
| J7050 |
Infusion, normal saline solution, 250 cc |
5,692 |
2,485 |
$100K |
| 96417 |
|
1,106 |
775 |
$53K |
| 77014 |
|
707 |
54 |
$46K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
839 |
432 |
$45K |
| 99205 |
Prolong outpt/office vis |
465 |
463 |
$45K |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
1,760 |
726 |
$39K |
| 99215 |
Prolong outpt/office vis |
409 |
389 |
$31K |
| 96523 |
|
1,055 |
785 |
$28K |
| 77334 |
|
247 |
100 |
$24K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
248 |
248 |
$23K |
| 77336 |
|
366 |
162 |
$21K |
| J0897 |
Injection, denosumab, 1 mg |
12 |
12 |
$21K |
| 77301 |
|
24 |
12 |
$15K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
197 |
81 |
$14K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,994 |
1,249 |
$12K |
| 77427 |
|
80 |
36 |
$10K |
| 77290 |
|
109 |
51 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
101 |
101 |
$8K |
| 36000 |
|
254 |
141 |
$8K |
| 77263 |
|
31 |
24 |
$8K |
| 77300 |
|
109 |
50 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
228 |
220 |
$6K |
| 77338 |
|
24 |
12 |
$5K |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
428 |
294 |
$5K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
54 |
24 |
$5K |
| 96415 |
|
114 |
95 |
$4K |
| J9190 |
Injection, fluorouracil, 500 mg |
67 |
26 |
$3K |
| 96411 |
|
82 |
53 |
$2K |
| A4215 |
Needle, sterile, any size, each |
107 |
56 |
$2K |
| 99222 |
Initial hospital care, per day, moderate complexity |
26 |
26 |
$2K |
| 96416 |
|
22 |
12 |
$1K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
66 |
41 |
$422.39 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
37 |
24 |
$410.13 |
| Q0166 |
Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen |
36 |
23 |
$151.56 |
| A4927 |
Gloves, non-sterile, per 100 |
63 |
18 |
$3.86 |